Attached files
| file | filename |
|---|---|
| EX-10.19 - EX-10.19 - IDEXX LABORATORIES INC /DE | a1019esppplandocumentadopt.htm |
| EX-32.2 - EX-32.2 - IDEXX LABORATORIES INC /DE | exhibit3221.htm |
| EX-10.22 - EX-10.22 - IDEXX LABORATORIES INC /DE | a1022summaryeip.htm |
| EX-31.2 - EX-31.2 - IDEXX LABORATORIES INC /DE | exhibit3121.htm |
| EX-21 - EX-21 - IDEXX LABORATORIES INC /DE | exhibit211.htm |
| EX-32.1 - EX-32.1 - IDEXX LABORATORIES INC /DE | exhibit3211.htm |
| EX-31.1 - EX-31.1 - IDEXX LABORATORIES INC /DE | exhibit3111.htm |
| 10-K - 10-K - IDEXX LABORATORIES INC /DE | idxx-20201231.htm |
EXHIBIT 23
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (Nos. 333-36007 and 333-70846) and Form S-8 (Nos. 333-11201, 333-11199, 333-36009, 333-56685, 333-78765, 333-78769, 333-43172, 333-43170, 333-27733, 333-105426, 333-108905, 333-108906, 333-146479, 333-160083, 333-160085, 333-193136 and 333-204418) of IDEXX Laboratories, Inc. of our report dated February 12, 2021 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.
/s/ PricewaterhouseCoopers LLP
| Boston, Massachusetts | |||||
| February 12, 2021 | |||||